Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ivis Mendoza Hernandez"'
Autor:
Eduardo Ojito Magaz, Daniel G. Rivera, Ariel Palenzuela Diaz, Yanelda Garcia Vega, Leslihana Verdecia Sanchez, Tammy Boggiano Ayo, Meybis Rodriguez Gonzalez, Belinda Sánchez Ramírez, Anitza Fraga Quintero, Ivis Mendoza Hernandez, Yury Valdés Balbin, Franciscary Pi Estopinan, Guang-Wu Chen, Beatriz Perez Masson, Yanet Climent Ruiz, Sonsire Fernandez Castillo, Gretchen Bergado Báez, Otto Cruz Sui, Beatriz Paredes Moreno, Carmen Valenzuela Silva, Tays Hernandez Garcia, Gerardo Baro Roman, Dagmar García Rivera, Darielys Santana Mederos, Laura Rodriguez Noda, Vicente Verez Bencomo, Ubel Ramirez Gonzalez, Rocmira Perez Nicado, María Eugenia Toledo-Romaní, Raul Gonzalez Mugica, Majela Garcia Montero
BackgroundSOBERANA 02 is a COVID-19 conjugate vaccine candidate based on SARS-CoV-2 recombinant RBD conjugated to tetanus toxoid. SOBERANA Plus antigen is dimeric-RBD. Here we report safety, reactogenicity and immunogenicity from phase I and IIa clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::585980601f45319168ec11e934bb3723
https://doi.org/10.1101/2021.11.14.21266309
https://doi.org/10.1101/2021.11.14.21266309
Autor:
Kirenia Camacho Sosa, Mayra Ramos Suzarte, Carmen Elena Viada González, Elia Nenínger Vinageras, Eduardo Rafael Santiesteban Álvarez, Maurenis Hernández Pérez, Yoanna Ivette Flores Vega, Saylin Alfonso Alemán, Ramón Alberto Ortiz Carrodeguas, Soraida Candida Acosta Brooks, Pedro Pablo Guerra Chaviano, Ivis Mendoza Hernández, Tania Crombet Ramos, Agustín Lage Dávila
Publikováno v:
Revista Cubana de Medicina Militar, Vol 52, Iss 3, Pp e02303004-e02303004 (2023)
Introduction: The response to therapies in advanced lung cancer could be related to certain prognostic factors such as inflammatory indices. Objective: To evaluate the efficacy of the humanized monoclonal antibody nimotuzumab in patients with advance
Externí odkaz:
https://doaj.org/article/e192693e6d24410daf2fcef4ca8c7838
Autor:
Alicia Vargas Batista, Jorge Pérez-Oliva Díaz, Maytée Robaina García, Patricia Piedra Sierra, Ivis Mendoza Hernández, Yusnely Román Rodríguez
Publikováno v:
Revista Habanera de Ciencias Médicas, Vol 15, Iss 6, Pp 1029-1041 (2016)
Introducción: El ior® EPOCIM (eritropoyetina humana recombinante), es un medicamento cubano que se produce en el Centro de Inmunología Molecular, el cual ha resultado ser seguro y no se han reportado eventos adversos graves asociados a su uso en p
Externí odkaz:
https://doaj.org/article/d34200a8c0dc403bb5fe6d77140b6123
Autor:
Liermis Michael Dita Salabert, Ivis Mendoza Hernández, Rafael Alejandro Gómez Baute, Elena García López, Lázaro E. de la Cruz Avilés, Aramis Núñez Quintana
Publikováno v:
Medisur, Vol 8, Iss 4, Pp 280-288 (2010)
Many of the drugs that has shown promise in the treatment of hematologic malignancies and solid tumors, associated with a high potential cardiotoxic. Within this group stand anthracyclines, identified as the type of chemotherapy most likely to cause
Externí odkaz:
https://doaj.org/article/801786fae5814a80bb3f3955fa58b065